Clinical/Forensics
Fast Screening and Confirmation for Gamma-Hydroxybutyrate (GHB)
(con tinued from page 3)
the ir euphori c and seda tive properties. 1,4
butanediol and GEL are quickly metabolized to
GHE after ingestion and are analyzed as such.
Because GHE is endogenous in humans, and has a
half-life of one hour or less after injection, it is very
important to collect biofluids (typically blood or
urine) quickly for toxicological investigation.
Analytical methods for GHB usually emplo y gas
chromatography and mass spectrometry for quan
tification and confirmation . The methodology
described here establishes a headspace GC-FID
screening procedure followed by confirmation and
quantification by headspace
GC/MS,
and was
developed by the FBI Chemistry Unit.' We have
adapt ed Rtx®-BACI and Rtx®-BAC2 columns
with court-tested and pro ven performance in
blood alcoho l analyses- and new, highly inert
Rxi™-SMS columns to the methods.
A typical headspace GC-FID blood alcohol system,
using an Rtx®-BACI column or an Rtx®-EAC2
column, can be adapted for GHB screening. For
the analysis, GHB is converted to gamma-butyro
lacton e (GBL) to impro ve chromatography, and
alpha -methylene-gamma-butyrolactone (AMGB)
is used as the internal standard. Figure 1 illustrates
the conversion reaction of GHE to GBL. Figure 2
shows that either Restek column is suitabl e for
GHB screening , providing Gaussian peak shapes,
baseline resolut ion , and an analysis time of less
than 5 minutes.
A sample yieldin g positive screening results
requi res confirmation and qu ant ification by
GC/MS. The confirmation and quantification
analysis incorp orat es the same headspace and GC
conditions, including conversion of GHB to GEL,
but GBL-d6 is the required internal standard. To
illustrate GBL and GEL-d6 separation and peak
shape on an RxjTM-5ms column we analyzed Iul, of
a standa rd, using GC/MS. (Figure 3). Thi s typical
liquid injection shows the two compounds are par
tially resolved on the Rxi™-Sms column, and pos
itively ident ified using full scan. Then, extracted
ion data (EI) were obtained(Figure 4). After posi
tive identification, GHB is quantified by compa r
ing the areas of the deuterated and und euterated
GEL extracted ions.
Figure 1 Conversion of GHB to GBL.
- - - - .HO
~
~OH
gamma-hydroxybutyrate
gamma-butyrolactone
(GHB)
(GBL)
2006.03
Figure 2 Symmetric peak for GHB, and baseline resolut ion from an
inte rnal standard in less tha n 5 minutes, using an Rtx
llD
-BACl or
Rtx
llD
-BACl Column .
Rtx
llD-BACl
column
Sharp peaks and baseline
resolution in less than 5 minutes
12 samples per hour!
1. gamma-hydroxybutyrate (GHB) / gamma-butyrolactone (GBl)
2. alpha-methylene-gamma-butyrolactone (AMGBl)
i
I
I
I
I
I
I
4
6
8
10
Time(min)
GC_PIlOO870
2
Rtx
llD
-BAC2 column
1
I
0
I
I
2
I
i
4
1
Time(min)
I
6
1
I
8
i
I
10
GC..
PHOO871
Column:
Rtx'-BACl 30m, 0.32mm !D,
1.8IJm
(cat.# 18003) and
Rtx' -BAC2 30m, 0.32mm!D, 1.2pm(cat.# 18002),
connectedvia universal"Y" Press-Tight' connector (cat.# 20405)
Sample:
GHB, GBL,cx-methylene--y-butyrolactone(AMGBl), lO/Jg/ ml each in water
Inj.:
1.0mlheadspace, split (splitratio 1:10), l rnrnsplit inlet liner (cat.# 20972)
Inj. temp.:
200' C
Carrier gas:
helium, constant pressure
linear velocity:
44cm/sec.
@
50' C
Oven temp.:
50' C(3 min.) to 150'C
@
20' C/min. (hold7 min.)
Det:
F!D
@
240'C
Headspace autosampler: Teledyne/Tekmar HT3
Sample/ platen temp.:
100' C
Sample equilibration:
15min.
Mixing time:
5 min.
Vial pressure:
10psig
Vial pressurization
time:
2min.
l oopfill time:
2min.
Transfer line temp.:
120'C
Drug -Facilitated Sexual Assault : A Forensic Handbook
This unique handbook educates readers about how drugs are used in sexual
assaults.
It
is important reading for any involved in investigating these
crimes, including forensic scientists, law enforcement officers, lawyers, toxi
cologists, and medical professionals.
M. LeBeau and A. Mozayani, Eds., Academic Press, 2001, 326pp.,
ISBN 0-12-440261-5
cat.#
23054 (ea.) $84.95
800 -356-1688 •
www.restek.com• 4 •
Website :
www.chromtech.net.auE-mail :
info@chromatech.net.auTelNo : 03 9762 2034 . . . in AUSTRALIA